Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Apr;57(4):390–394. doi: 10.1038/bjc.1988.88

Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy.

D K Sinha 1, J E Pazik 1, T L Dao 1
PMCID: PMC2246553  PMID: 3134040

Abstract

In this study, the role of parity in conferring protection of the mammary gland against chemical carcinogenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA) was investigated. Experiments were also carried out to determine if an 'interrupted' pregnancy was capable of reducing the incidence of mammary tumour induction. Since it has been suggested that morphological development or the proliferative pattern of the mammary gland at the time of carcinogen administration may be involved in reducing the susceptibility of the mammary gland to chemical carcinogenesis, experiments were designed to elucidate the possible influence of these two factors. Sprague-Dawley female rats were mated and were either allowed to complete pregnancy and parturition or were subjected to Caesarian section on day 5, 10 or 15 of the pregnancy. When DMBA was administered i.v. to animals which had been allowed to complete a full-term pregnancy, only 14% developed tumours, compared to 70% in age-matched nulliparous controls. Termination of the pregnancy on days 5, 10 or 15 was as effective in reducing tumour incidence as full-term gestation and parturition, but still resulted in partial and statistically significant inhibition, compared to age-matched nulliparous controls. There was no significant difference in 3H-thymidine labelling index (LI) at the time of DMBA treatment in the parous rats compared to age-matched nulliparous controls. We also observed no significant differences in the morphological development of the mammary gland in parous and nulliparous rats of the same age. These results indicate that the protective mechanism may not lie in the mammary gland per se, but may indeed be a host factor, such as hormonal or immunological changes occurring in the host as a result of the pregnancy.

Full text

PDF
390

Images in this article

392Figure 2
on p.392
392Figure 3
on p.392
392Figure 4
on p.392
392Figure 5
on p.392
392Figure 6
on p.392
392Figure 7
on p.392

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Grudzinskas J. G., Coombes R. C., Ratcliffe J. G., Gordon Y. B., Powles T. J., Neville A. M., Chard T. Circulating levels of pregnancy specific beta 1 glycopretein in patients with testicular, bronchogenic and breast carcinomas. Cancer. 1980 Jan 1;45(1):102–103. doi: 10.1002/1097-0142(19800101)45:1<102::aid-cncr2820450118>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  2. Heyner S. Detection of H-2 antigens on the cells of the early mouse embryo. Transplantation. 1973 Dec;16(6):675–678. [PubMed] [Google Scholar]
  3. Lin F. K., Banerjee M. R., Crump L. R. Cell cycle-related hormone carcinogen interaction during chemical carcinogen induction of nodule-like mammary lesions in organ culture. Cancer Res. 1976 May;36(5):1607–1614. [PubMed] [Google Scholar]
  4. Loke Y. W., Joysey V. C., Borland R. HL-A antigens on human trophoblast cells. Nature. 1971 Aug 6;232(5310):403–405. doi: 10.1038/232403a0. [DOI] [PubMed] [Google Scholar]
  5. MARCHANT J. Influence of pregnancy and lactation on the incidence of mammary carcinoma induced with methylcholanthrene in female mice of the "IF" strain. J Pathol Bacteriol. 1955 Oct;70(2):415–418. doi: 10.1002/path.1700700218. [DOI] [PubMed] [Google Scholar]
  6. MARCHANT J. Local inhibition by lactation of chemically induced breast tumours in mice of the IF strain. Nature. 1959 Feb 28;183(4661):629–629. doi: 10.1038/183629a0. [DOI] [PubMed] [Google Scholar]
  7. MacMahon B., Cole P., Brown J. Etiology of human breast cancer: a review. J Natl Cancer Inst. 1973 Jan;50(1):21–42. doi: 10.1093/jnci/50.1.21. [DOI] [PubMed] [Google Scholar]
  8. Monteiro J. C., Biswas S., Al-Awqati M. A., Greening W. P., McKinna J. A., Neville A. M. Serum levels of human placental lactogen and pregnancy-specific beta 1-glycoprotein in breast cancer. Br J Cancer. 1982 Aug;46(2):279–282. doi: 10.1038/bjc.1982.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nagasawa H., Vorherr H. Rat mammary deoxyribonucleic acid synthesis during the estrous cycle, pregnancy, and lactation in relation to mammary tumorigenesis: its implication for human breast cancer. Am J Obstet Gynecol. 1977 Mar 15;127(6):590–593. doi: 10.1016/0002-9378(77)90354-4. [DOI] [PubMed] [Google Scholar]
  10. Patthey H., Edidin M. Evidence for the time of appearance of H-2 antigens in mouse development. Transplantation. 1973 Feb;15(2):211–214. doi: 10.1097/00007890-197302000-00004. [DOI] [PubMed] [Google Scholar]
  11. Ravnihar B., MacMahon B., Lindtner J. Epidemiologic features of breast cancer in Slovenia, 1965-1967. Eur J Cancer. 1971 Aug;7(4):295–306. doi: 10.1016/0014-2964(71)90072-7. [DOI] [PubMed] [Google Scholar]
  12. Russo J., Russo I. H. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol. 1980 Aug;100(2):497–512. [PMC free article] [PubMed] [Google Scholar]
  13. Sellens M. H., Jenkinson E. J., Billington W. D. Major histocompatibility complex and non-major histocompatibility complex antigens on mouse ectoplacental cone and placental trophoblastic cells. Transplantation. 1978 Apr;25(4):173–179. doi: 10.1097/00007890-197804000-00003. [DOI] [PubMed] [Google Scholar]
  14. Sinha D. K., Dao T. L. Induction of mammary tumors in aging rats by 7,12-dimethylbenz[a]anthracene: role of DNA synthesis during carcinogenesis. J Natl Cancer Inst. 1980 Mar;64(3):519–521. [PubMed] [Google Scholar]
  15. Sinha D. K., Pazik J. E., Dao T. L. Progression of rat mammary development with age and its relationship to carcinogenesis by a chemical carcinogen. Int J Cancer. 1983 Mar 15;31(3):321–327. doi: 10.1002/ijc.2910310312. [DOI] [PubMed] [Google Scholar]
  16. Sinha D. K., Pazik J. E. Tumorigenesis of mammary gland by 7,12-dimethylbenz(a)anthracene during pregnancy: relationship with DNA synthesis. Int J Cancer. 1981 Jun 15;27(6):807–810. doi: 10.1002/ijc.2910270612. [DOI] [PubMed] [Google Scholar]
  17. Valaoras V. G., MacMahon B., Trichopoulos D., Polychronopoulou A. Lactation and reproductive histories of breast cancer patients in greater Athens, 1965-67. Int J Cancer. 1969 May 15;4(3):350–363. doi: 10.1002/ijc.2910040312. [DOI] [PubMed] [Google Scholar]
  18. Vessey M. P., McPherson K., Yeates D., Doll R. Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. Br J Cancer. 1982 Mar;45(3):327–331. doi: 10.1038/bjc.1982.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vonderhaar B. K., Topper Y. J. A role of the cell cycle in hormone-dependent differentiation. J Cell Biol. 1974 Nov;63(2 Pt 1):707–712. doi: 10.1083/jcb.63.2.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. WYNDER E. L., BROSS I. J., HIRAYAMA T. A study of the epidemiology of cancer of the breast. Cancer. 1960 May-Jun;13:559–601. doi: 10.1002/1097-0142(196005/06)13:3<559::aid-cncr2820130322>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  21. Wegmann T. G., Mosmann T. R., Carlson G. A., Olijnyk O., Singh B. The ability of the murine placenta to absorb monoclonal anti-fetal H-2K antibody from the maternal circulation. J Immunol. 1979 Sep;123(3):1020–1023. [PubMed] [Google Scholar]
  22. Yuasa S., MacMahon B. Lactation and reproductive histories of breast cancer patients in Tokyo, Japan. Bull World Health Organ. 1970;42(2):195–204. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES